Development of molecular assays based on epigenetic biomarkers which allow early and reliable cancer diagnostics – this is the intention of oncgnostics!
Our products should allow an early detection of diseases to substantially inprove therapy success. Notice: if detected early, almost all cancer cases are curable.
If you would like us to keep you informed about news related to our company, please sign in for our quarterly newsletter.
https://www.oncgnostics.com/wp-content/uploads/2021/08/210804_BildZelleEpigenetic_Blog.jpg
345
876
TowerPR
https://www.oncgnostics.com/wp-content/uploads/2015/03/oncgnostics-logo1-300x138.png
TowerPR2021-08-12 09:18:052021-08-12 09:27:37Epigenetic markers – definition and significance for early cancer detection
shutterstock.com 1936727821
https://www.oncgnostics.com/wp-content/uploads/2021/08/210805_shutterstock_1936727821.jpg
345
876
TowerPR
https://www.oncgnostics.com/wp-content/uploads/2015/03/oncgnostics-logo1-300x138.png
TowerPR2021-08-09 11:45:132021-08-09 11:45:13Pilot study: Cancer screening from home is possible
https://www.oncgnostics.com/wp-content/uploads/2021/07/210706_Step-USA_WP.jpg
836
2014
TowerPR
https://www.oncgnostics.com/wp-content/uploads/2015/03/oncgnostics-logo1-300x138.png
TowerPR2021-07-09 09:01:152021-07-09 09:09:37Step USA – our virtual business tripOur fist product, GynTect®, enables reliable and fast diagnosis of cervical cancer and pre-cancerous stages.
Video in German.
